R Ram Sharma π Coach β 193.88K Points π Biopharmaceutics and Pharmacokinetic Q. Multiple dose study is better since we can understand the peak, valley, drug blood levels, etc. (A) True (B) False (C) none (D) all ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) True
R Rakesh Kumar π Hard Worker β 28.44K Points π Biopharmaceutics and Pharmacokinetic Q. Single-dose bioavailability studies are simple and common. (A) True (B) False (C) none (D) all ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) True
R Ram Sharma π Coach β 193.88K Points π Biopharmaceutics and Pharmacokinetic Q. Which of the following is not an objective of bioavailability studies? (A) Primary stages of development of suitable dosage form for new drug (B) Determination of the influence of excipients, patient-related factors, etc (C) Development of new formulations of the existing drugs (D) Control the quantity of the drug to be administered ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) Control the quantity of the drug to be administered
S Shiva Ram π Master β 30.44K Points π Biopharmaceutics and Pharmacokinetic Q. What is the equation of bioavailable fraction? (A) 1/Bioavailable dose (B) 1/Administered dose (C) Bioavailable dose/Administered dose (D) Administered dose/Bioavailable dose ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) Bioavailable dose/Administered dose
P Priyanka Tomar π Tutor III β 35.28K Points π Biopharmaceutics and Pharmacokinetic Q. What is bioavailability? (A) The time of absorption of the drug from its dosage form (B) The rate of absorption of the unchanged drug from its dosage form (C) The time of absorption of the unchanged drug from its dosage form (D) The rate of absorption of the drug from its dosage form ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) The rate of absorption of the unchanged drug from its dosage form
R Ram Sharma π Coach β 193.88K Points π Biopharmaceutics and Pharmacokinetic Q. Bioavailability of drug from topical administration is affected by….. (A) Skin condition (B) Topical vehicle (C) Application condition (D) all of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) all of the above
R Ram Sharma π Coach β 193.88K Points π Biopharmaceutics and Pharmacokinetic Q. Bioavailability from IV route is……% (A) 10 (B) 100 (C) 1000 (D) 10000 ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) 100
G Gopal Sharma π Tutor III β 38.32K Points π Biopharmaceutics and Pharmacokinetic Q. USP dissolution test apparatus type-II is also called as….. (A) Hansen paddle type (B) paddle over disc (C) Rotating basket type (D) none of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Hansen paddle type
R Ram Sharma π Coach β 193.88K Points π Biopharmaceutics and Pharmacokinetic Q. Ex-vivo models refer to……. (A) in the body (B) in the computer (C) outside the body (D) none of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) outside the body
P Priyanka Tomar π Tutor III β 35.28K Points π Biopharmaceutics and Pharmacokinetic Q. Non-invasive measurement of drug concentration includes ……….sampling. (A) hair (B) urine (C) saliva (D) All of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) All of the above